These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9311557)
1. Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugate. Boitte N; Pommery N; Colson P; Houssier C; Waring MJ; Hénichart JP; Bailly C Anticancer Drug Des; 1997 Sep; 12(6):481-501. PubMed ID: 9311557 [TBL] [Abstract][Full Text] [Related]
2. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632 [TBL] [Abstract][Full Text] [Related]
3. Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin. Henichart JP; Waring MJ; Riou JF; Denny WA; Bailly C Mol Pharmacol; 1997 Mar; 51(3):448-61. PubMed ID: 9058600 [TBL] [Abstract][Full Text] [Related]
4. Design of composite drug molecules: mutual effects on binding to DNA of an intercalator, amsacrine, and a minor groove binder, netropsin. Bourdouxhe C; Colson P; Houssier C; Hénichart JP; Waring MJ; Denny WA; Bailly C Anticancer Drug Des; 1995 Mar; 10(2):131-54. PubMed ID: 7710635 [TBL] [Abstract][Full Text] [Related]
5. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism. Bailly C; Hénichart JP; Colson P; Houssier C J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484 [TBL] [Abstract][Full Text] [Related]
6. Interaction of a DNA-threading netropsin-amsacrine combilexin with DNA and chromatin. Bourdouxhe-Housiaux C; Colson P; Houssier C; Waring MJ; Bailly C Biochemistry; 1996 Apr; 35(14):4251-64. PubMed ID: 8605173 [TBL] [Abstract][Full Text] [Related]
7. Carbocyclic analogues of netropsin and distamycin: DNA-binding properties and inhibition of DNA topoisomerases. Bartulewicz D; Bielawski K; Bielawska A Arch Pharm (Weinheim); 2002 Nov; 335(9):422-6. PubMed ID: 12447915 [TBL] [Abstract][Full Text] [Related]
8. Camptothecin conjugated with DNA minor-groove binder netropsin: enhanced lactone stability, inhibition of human DNA topoisomerase I and antiproliferative activity. Sukhanova A; Grokhovsky S; Zhuze A; Devy J; Pluot M; Oleinikov V; Nabiev I Anticancer Res; 2003; 23(3B):2609-15. PubMed ID: 12894548 [TBL] [Abstract][Full Text] [Related]
9. Aromatic analogues of DNA minor groove binders--synthesis and biological evaluation. Pućkowska A; Bielawski K; Bielawska A; Midura-Nowaczek K Eur J Med Chem; 2004 Jan; 39(1):99-105. PubMed ID: 14987838 [TBL] [Abstract][Full Text] [Related]
10. Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNA. Plouvier B; Houssin R; Helbecque N; Colson P; Houssier C; Hénichart JP; Bailly C Anticancer Drug Des; 1995 Mar; 10(2):155-66. PubMed ID: 7710636 [TBL] [Abstract][Full Text] [Related]
11. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects. De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987 [TBL] [Abstract][Full Text] [Related]
12. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction. Bell A; Kittler L; Löber G; Zimmer C J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648 [TBL] [Abstract][Full Text] [Related]
13. Psoralen--lexitropsin hybrids: DNA sequence selectivity of photoinduced cross-linking from MPE footprinting and exonuclease III stop assay, and mode of binding from electric linear dichroism. Rao KE; Gosselin G; Mrani D; Périgaud C; Imbach JL; Bailly C; Hénichart JP; Colson P; Houssier C; Lown JW Anticancer Drug Des; 1994 Jun; 9(3):221-37. PubMed ID: 8031454 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and topoisomerase II inhibition activity of 4'-demethylepipodophyllotoxin-lexitropsin conjugates. Gupta R; al-Said NH; Oreski B; Lown JW Anticancer Drug Des; 1996 Jun; 11(4):325-38. PubMed ID: 8679055 [TBL] [Abstract][Full Text] [Related]
15. Sequence-recognition and cleavage of DNA by a netropsin-phenazine-di-N-oxide conjugate. Helissey P; Giorgi-Renault S; Colson P; Houssier C; Bailly C Bioconjug Chem; 2000; 11(2):219-27. PubMed ID: 10725099 [TBL] [Abstract][Full Text] [Related]
16. DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency. Guo D; Gupta R; Lown JW Anticancer Drug Des; 1993 Oct; 8(5):369-97. PubMed ID: 8251044 [TBL] [Abstract][Full Text] [Related]
17. DNA recognition by intercalators and hybrid molecules. Waring MJ; Bailly C J Mol Recognit; 1994 Jun; 7(2):109-22. PubMed ID: 7826671 [TBL] [Abstract][Full Text] [Related]
18. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Bonjean K; De Pauw-Gillet MC; Defresne MP; Colson P; Houssier C; Dassonneville L; Bailly C; Greimers R; Wright C; Quetin-Leclercq J; Tits M; Angenot L Biochemistry; 1998 Apr; 37(15):5136-46. PubMed ID: 9548744 [TBL] [Abstract][Full Text] [Related]
19. Design of a composite ethidium-netropsin-anilinoacridine molecule for DNA recognition. Carrasco C; Helissey P; Haroun M; Baldeyrou B; Lansiaux A; Colson P; Houssier C; Giorgi-Renault S; Bailly C Chembiochem; 2003 Jan; 4(1):50-61. PubMed ID: 12512076 [TBL] [Abstract][Full Text] [Related]